Become A Featured Company

Wellness Pioneer Branches into Cannabis with Groundbreaking Technology Platform

Ryan Allway

August 20th, 2021

App, Exclusive, News, Top Story

Nature is the lifeblood of the health and wellness industry. In fact, rainforest plants account for the raw material to produce a quarter of Western pharmaceuticals, including more than 120 different drugs. The challenge is understanding natural compounds and converting them into a format that maximizes their benefits to humans.

Let’s take a look at BioHarvest Sciences Ltd.’s (CSE: BHSC) (OTC: CNVCF) (FSE: 8MV) unique approach to plant products and why investors should take a closer look at the stock.

Realizing the Benefits of Nature

Most people recognize the importance of diet to their health and well-being, but eating healthy comes with its own set of challenges. At the same time, some beneficial active ingredients are impractical to consume in sufficient quantities through diet alone. These challenges led some scientists to explore ways to better harness the power of nature.

BioHarvest scientists began with the mission of harnessing the benefits of red wine without the sugar, calories, and alcohol. After over ten years of research and $40 million in investment, the company built a scalable biofarming platform to transform a single grape cell high in Piceid Resveratrol and other polyphenols (such as catechin, quercetin, anthocyanins, and tannins) into an unlimited quantity of exact copies.

The process involves a few steps:

  1. The team selects an ideal plant for the desired phytochemicals.
  2. The team isolates the desired cells and inserts them into a nutrient-packed Petri dish stored in a controlled environment.
  3. These cells grow into a “cell bank” used for perpetual production without the need for another live plant.
  4. The cells are grown in liquid mediums for three weeks at a time to reach adequate biomass.
  5. The biomass is harvested and dried into a final powder that contains the desired phytochemicals.

There are many benefits to the process:

  • Less Time: Three-week cycles accomplish as much as it takes nature one year to complete with a much sharper focus.
  • Less Waste: The process doesn’t involve chemicals, uses far less energy and land, and produces no hazardous waste.
  • More Consistency: The process results in cells with the same genetic fingerprint as the parent plant cell.
  • Better Safety: There are no dangerous chemicals or potential for plant-based infections, as occur in agriculture.

After spending more than a decade on research, the company launched VINIA®, a resveratrol supplement backed by eight scientific studies, three clinical trials, and 14 patents. The supplement provides as much resveratrol as a bottle of wine in each pill to support heart health , improve physical energy, and boost mental alertness via increased blood flow and delivery of oxygen and nutrients to the body’s tissues and organs.

Click the image below to watch a video on how Vinia® works:

Expanding into Cannabinoids

BioHarvest’s unique biofarming platform can scale the production of nearly any phytochemical, making it broadly applicable across the wellness market. So, with the legalization of cannabis in Canada, the team began to explore the potential for biofarming cannabinoids to address many concerns facing the industry.

The cannabis plant has hundreds of cannabinoids and terpenes that could offer a range of benefits. While scientific research is still playing catch up, the industry’s rapid growth introduced several growing pains. Pesticides are commonplace, and the plant requires a significant amount of water and light to grow even in fully compliant grows.

Furthermore, cannabis producers only use a fraction of the plant’s biomass for most consumer products. For example, most products don’t use leaves, stalks, root balls, and failed plants. Meanwhile, growers must process flowers through various extraction techniques to get the THC, CBD, or other desired cannabinoids from the plant material.

BioHarvest’s unique platform eliminates waste and ensures product consistency on a genetic level. In addition to a much lower CapEx and smaller footprint, the company’s scalable technology removes the risk of contamination and ensures a consistent experience for consumers. It’s a win-win-win for the environment, shareholders, and consumers.

Click here to receive an investor presentation and corporate updates

Recently, the company announced that it has successfully grown multiple trichomes attached together in natural coral-shaped structures. The structure protects the trichomes from damage and guarantees mechanical stability during the growth process. Management believes that the breakthrough will help it scale up commercialization during the first half of next year.

Looking Ahead

BioHarvest plans to continue developing its cannabis commercialization program through the remainder of 2021 before starting production in 2022. With numerous other potential products, such as olives and pomegranates, and markets, such as cosmetics or proteins, the company’s addressable market could be in the hundreds of billions of dollars each year.

As part of its quest to harvest the benefits of natural resources, the company has doubled down on its commitment to nature with the release of its first sustainability report, which highlights the unique sustainability advantages of its BioFarming technology along with specific sustainability goals through 2025 along with specific benchmarks to measure success. These factors make it potentially suitable for ESG-focused portfolios.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading